Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Leiner Looks To Distribute U.S. OTCs In December, Production Start Unknown

This article was originally published in The Tan Sheet

Executive Summary

Leiner Health Products could restart distributing some of its OTC products as early as December, but the resumption of its U.S. OTC manufacturing operations is still undetermined, the firm said Nov. 9

You may also be interested in...



Leiner Closing Plant, Changes Executives To Prepare For Re-entering Market

Leiner Health Products is closing its Wilson, N.C., over-the-counter manufacturing facility to reduce operating expenses as its re-entry to the OTC market is delayed, the firm states in recent filings with the Securities and Exchange Commission

Leiner Closing Plant, Changes Executives To Prepare For Re-entering Market

Leiner Health Products is closing its Wilson, N.C., over-the-counter manufacturing facility to reduce operating expenses as its re-entry to the OTC market is delayed, the firm states in recent filings with the Securities and Exchange Commission

Leiner Closing Plant, Changes Executives To Prepare For Re-entering Market

Leiner Health Products is closing its Wilson, N.C., over-the-counter manufacturing facility to reduce operating expenses as its re-entry to the OTC market is delayed, the firm states in recent filings with the Securities and Exchange Commission

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS101091

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel